{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:12:41Z","timestamp":1792793561992,"version":"4.5.0"},"reference-count":72,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n There are no approved treatments for nonalcoholic fatty liver disease (NAFLD) despite its association with obesity and increased risk of cardiovascular disease (CVD).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the association between bariatric surgery and CVD risk in individuals with severe obesity and NAFLD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This large, population-based retrospective cohort study obtained data from the MarketScan Commercial Claims and Encounters database from January 1, 2007, to December 31, 2017. Participants included insured adults aged 18 to 64 years with NAFLD and severe obesity (body mass index \u226540) without a history of bariatric surgery or CVD before NAFLD diagnosis. Baseline characteristics were balanced between individuals who underwent surgery (surgical group) and those who did not (nonsurgical group) using inverse probability of treatment weighting. Data were analyzed from March 2020 to April 2021.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures) vs nonsurgical care.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcome was the incidence of cardiovascular events (primary or secondary composite CVD outcomes). The primary composite outcome included myocardial infarction, heart failure, or ischemic stroke, and the secondary composite outcome included secondary ischemic heart events, transient ischemic attack, secondary cerebrovascular events, arterial embolism and thrombosis, or atherosclerosis. Cox proportional hazards regression models with inverse probability treatment weighting were used to examine the associations between bariatric surgery, modeled as time varying, and all outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study included 86\u202f964 adults (mean [SD] age, 44.3 [10.9] years; 59\u202f773 women [68.7%]). Of these individuals, 30\u202f300 (34.8%) underwent bariatric surgery and 56\u202f664 (65.2%) received nonsurgical care. All baseline covariates were balanced after applying inverse probability treatment weighting. In the surgical group, 1568 individuals experienced incident cardiovascular events compared with 7215 individuals in the nonsurgical group (incidence rate difference, 4.8 [95% CI, 4.5-5.0] per 100 person-years). At the end of the study, bariatric surgery was associated with a 49% lower risk of CVD (adjusted hazard ratio [aHR], 0.51; 95% CI, 0.48-0.54) compared with nonsurgical care. The risk of primary composite CVD outcomes was reduced by 47% (aHR, 0.53 [95% CI, 0.48-0.59), and the risk of secondary composite CVD outcomes decreased by 50% (aHR, 0.50; 95% CI, 0.46-0.53) in individuals with vs without surgery.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Results of this study suggest that, compared with nonsurgical care, bariatric surgery was associated with significant reduction in CVD risk in individuals with severe obesity and NAFLD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.35003","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:31:17Z","timestamp":1665142277000},"page":"e2235003","source":"Crossref","is-referenced-by-count":61,"title":["Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease"],"prefix":"10.1001","volume":"5","author":[{"given":"Mohamed I.","family":"Elsaid","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus"},{"name":"Secondary Data Core, Center for Biostatistics, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F. P.","family":"Bridges","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus"},{"name":"Department of Surgery, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brock","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus"},{"name":"Secondary Data Core, Center for Biostatistics, College of Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Minacapelli","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Rustgi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey"},{"name":"Center for Liver Diseases and Masses, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"issue":"22","key":"zoi220994r1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review.","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"zoi220994r2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"zoi220994r3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cld.2004.04.004","article-title":"The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.","volume":"8","author":"McCullough","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"8","key":"zoi220994r4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease.","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"4","key":"zoi220994r5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"zoi220994r6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"zoi220994r7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"zoi220994r8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome.","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"13","key":"zoi220994r9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"zoi220994r10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.gastha.2022.02.002","article-title":"Metabolic syndrome severity predicts mortality in nonalcoholic fatty liver disease.","volume":"1","author":"Elsaid","year":"2022","journal-title":"Gastro Hep Advances"},{"issue":"2","key":"zoi220994r11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"zoi220994r12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003921","article-title":"Obesity and subtypes of incident cardiovascular disease.","volume":"5","author":"Ndumele","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7121","key":"zoi220994r13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease.","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"issue":"9","key":"zoi220994r14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/CIRCULATIONAHA.111.022541","article-title":"Obesity and cardiovascular disease.","volume":"125","author":"Apovian","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"zoi220994r15","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"7","key":"zoi220994r16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.cgh.2020.07.030","article-title":"Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease.","volume":"19","author":"Meyersohn","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"zoi220994r17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/124958","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis.","volume":"2013","author":"Lu","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"2","key":"zoi220994r18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications.","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"issue":"2","key":"zoi220994r19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"issue":"3","key":"zoi220994r20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis.","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"zoi220994r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease.","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"issue":"10290","key":"zoi220994r22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"zoi220994r23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cld.2015.10.008","article-title":"Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease.","volume":"20","author":"Hannah","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"1","key":"zoi220994r24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2012.02.023","article-title":"Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"57","author":"Keating","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"zoi220994r25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise.","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"zoi220994r26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease.","volume":"52","author":"Makri","year":"2021","journal-title":"Arch Med Res"},{"issue":"12","key":"zoi220994r27","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"zoi220994r28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.soard.2018.12.002","article-title":"Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.","volume":"15","author":"Fakhry","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"zoi220994r29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients.","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi220994r30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2021.03.017","article-title":"Effect of endoscopic bariatric and metabolic therapies on nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"20","author":"Jirapinyo","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi220994r31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events.","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"issue":"15","key":"zoi220994r32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.120.052386","article-title":"Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study.","volume":"143","author":"Doumouras","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"zoi220994r33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.7326\/M17-2383","article-title":"Microvascular outcomes in patients with diabetes after bariatric surgery versus usual care: a matched cohort study.","volume":"169","author":"O\u2019Brien","year":"2018","journal-title":"Ann Intern Med"},{"issue":"13","key":"zoi220994r34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity.","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"issue":"20","key":"zoi220994r35","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis.","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"zoi220994r36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1055\/s-0038-1673354","article-title":"Truven Health Analytics MarketScan databases for clinical research in colon and rectal surgery.","volume":"32","author":"Kulaylat","year":"2019","journal-title":"Clin Colon Rectal Surg"},{"issue":"3","key":"zoi220994r37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States.","volume":"68","author":"Mellinger","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"zoi220994r38","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamainternmed.2017.2432","article-title":"Cardiovascular testing and clinical outcomes in emergency department patients with chest pain.","volume":"177","author":"Sandhu","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi220994r39","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1053\/j.gastro.2015.12.018","article-title":"Risks associated with anesthesia services during colonoscopy.","volume":"150","author":"Wernli","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"zoi220994r40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/M18-2217","article-title":"Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty: a cohort study.","volume":"170","author":"George","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi220994r41","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on health care utilization.","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"zoi220994r42","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hep.v67.5","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study.","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"zoi220994r44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi220994r45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/(ISSN)1097-0258","article-title":"A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.","volume":"3","author":"Simon","year":"1984","journal-title":"Stat Med"},{"issue":"345","key":"zoi220994r46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/01621459.1974.10480131","article-title":"Evaluation of response-time data involving transient states: an illustration using heart-transplant data.","volume":"69","author":"Mantel","year":"1974","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"zoi220994r47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi220994r48","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","article-title":"Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology.","volume":"25","author":"Bower","year":"2015","journal-title":"Obes Surg"},{"key":"zoi220994r49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fphys.2016.00344","article-title":"Roux-en Y gastric bypass results in long-term remission of hepatocyte apoptosis and hepatic histological features of non-alcoholic steatohepatitis.","volume":"7","author":"Schneck","year":"2016","journal-title":"Front Physiol"},{"issue":"3","key":"zoi220994r50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/joim.12012","article-title":"Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.","volume":"273","author":"Sj\u00f6str\u00f6m","year":"2013","journal-title":"J Intern Med"},{"issue":"22","key":"zoi220994r51","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"zoi220994r52","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.3390\/nu13103568","article-title":"Reduction of major adverse cardiovascular events (MACE) after bariatric surgery in patients with obesity and cardiovascular diseases: a systematic review and meta-analysis.","volume":"13","author":"Sutanto","year":"2021","journal-title":"Nutrients"},{"key":"zoi220994r53","doi-asserted-by":"publisher","first-page":"f5934","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"zoi220994r54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"zoi220994r55","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1007\/s11695-017-2866-4","article-title":"The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis.","volume":"27","author":"Sheng","year":"2017","journal-title":"Obes Surg"},{"issue":"20","key":"zoi220994r56","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi220994r57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2014.02.026","article-title":"Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis.","volume":"173","author":"Kwok","year":"2014","journal-title":"Int J Cardiol"},{"issue":"14","key":"zoi220994r58","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi220994r59","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"9","key":"zoi220994r60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"zoi220994r61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.soard.2021.11.015","article-title":"ASMBS position statement on the impact of metabolic and bariatric surgery on nonalcoholic steatohepatitis.","volume":"18","author":"Mazzini","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"zoi220994r62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/13696998.2022.2026702","article-title":"Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease.","volume":"25","author":"Rustgi","year":"2022","journal-title":"J Med Econ"},{"issue":"6","key":"zoi220994r63","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","article-title":"Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis.","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"zoi220994r64","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.amjcard.2011.06.076","article-title":"Effect of bariatric surgery on cardiovascular risk profile.","volume":"108","author":"Heneghan","year":"2011","journal-title":"Am J Cardiol"},{"issue":"1","key":"zoi220994r65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/SLA.0000000000003871","article-title":"Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis: a retrospective cohort analysis.","volume":"272","author":"Wirth","year":"2020","journal-title":"Ann Surg"},{"issue":"26","key":"zoi220994r66","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/eurheartj\/ehz295","article-title":"Surgical obesity treatment and the risk of heart failure.","volume":"40","author":"Jamaly","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"zoi220994r67","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity.","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"5","key":"zoi220994r68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure.","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi220994r69","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cardfail.2017.05.005","article-title":"Risk of heart failure in obese patients with and without bariatric surgery in Sweden\u2014a registry-based study.","volume":"23","author":"Persson","year":"2017","journal-title":"J Card Fail"},{"issue":"2","key":"zoi220994r70","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0047","article-title":"Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis.","volume":"2","author":"Klebanoff","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi220994r71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1053\/j.gastro.2021.03.021","article-title":"Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity.","volume":"161","author":"Rustgi","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"zoi220994r72","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/SLA.0000000000003554","article-title":"Changes in utilization of bariatric surgery in the United States from 1993 to 2016.","volume":"271","author":"Campos","year":"2020","journal-title":"Ann Surg"},{"key":"zoi220994r43","unstructured":"American Society for Metabolic and Bariatric Surgery. CPT and ICD-9 codes for bariatric surgery presented by the ASMBS insurance committee. 2013. Accessed December 4, 2019. http:\/\/content.asmbs.org\/tool-kits\/revisional\/11-CPTandICD-9-Codes-for-Bariatric-Surgery-updated-Feb-2013d-FINAL.pdf?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797180\/elsaid_2022_oi_220994_1664506613.37704.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:31:20Z","timestamp":1665142280000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.35003","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}